The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online June 26, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0803567
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0803567v1
183/2/1301    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Schreiber, T.
Right arrow Articles by Hölscher, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreiber, T.
Right arrow Articles by Hölscher, C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Medline Plus Health Information
*Tuberculosis

Autocrine IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity1

Tanja Schreiber*,2, Stefan Ehlers{dagger},{ddagger}, Lisa Heitmann*, Alexandra Rausch3,*, Jörg Mages§, Peter J. Murray, Roland Lang§,|| and Christoph Hölscher*,4

*Infection Immunology and {dagger}Microbial Inflammation Research, Research Center Borstel, Borstel, Germany; {ddagger}Molecular Inflammation Medicine, Christian Albrechts University, Kiel, Germany; §Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany; Department of Infectious Diseases and Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and ||Institute of Clinical Microbiology, University Hospital Erlangen, Erlangen, Germany

Elevated IL-10 has been implicated in reactivation tuberculosis (TB). Since macrophages rather than T cells were reported to be the major source of IL-10 in TB, we analyzed the consequences of a macrophage-specific overexpression of IL-10 in transgenic mice (macIL-10-transgenic) after aerosol infection with Mycobacterium tuberculosis (Mtb). MacIL-10 transgenic mice were more susceptible to chronic Mtb infection than nontransgenic littermates, exhibiting higher bacterial loads in the lung after 12 wk of infection and dying significantly earlier than controls. The differentiation, recruitment, and activation of Th1 cells as well as the induction of IFN-{gamma}-dependent effector genes against Mtb were not affected by macrophage-derived IL-10. However, microarray analysis of pulmonary gene expression revealed patterns characteristic of alternative macrophage activation that were overrepresented in Mtb-infected macIL-10 transgenic mice. Importantly, arginase-1 gene expression and activity were strikingly enhanced in transgenic mice accompanied by a reduced production of reactive nitrogen intermediates. Moreover, IL-10-dependent arginase-1 induction diminished antimycobacterial effector mechanisms in macrophages. Taken together, macrophage-derived IL-10 triggers aspects of alternative macrophage activation and promotes Mtb recrudescence independent of overt effects on anti-TB T cell immunity.

4Address correspondence and reprint requests to Dr. Christoph Hölscher, Infection Immunology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany. E-mail address: choelscher{at}fz-borstel.de

1 This work is supported by a research grant ("Host defence against infections") from the Medical University of Lübeck (to C.H.), Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Germany) Grants NIES05T22 (to S.E.), 01KI0784 (to S.E. and C.H.), and NGFN-2 FKZ 01GS0402 (to R.L.), the Deutsche Forschungsgemeinschaft La 1262/3-1 (to R.L.), and National Institutes of Health Grant AI062921 (to P.J.M.).

2 Current address: Center for Biological Safety, Robert Koch-Institute, Berlin, Germany.

3 Current address: GDD Common Mechanism Research, Bayer Schering Pharma AG, Berlin, Germany.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Sacks
BAC talk about cell type-specific regulation of human IL-10
PNAS, October 6, 2009; 106(40): 16895 - 16896.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.